{"id":5843,"date":"2026-05-20T06:01:01","date_gmt":"2026-05-20T06:01:01","guid":{"rendered":"https:\/\/pharmanomos.ch\/regulatory-due-diligence-why-it-is-critical-for-life-sciences-companies\/"},"modified":"2026-05-20T06:08:56","modified_gmt":"2026-05-20T06:08:56","slug":"regulatory-due-diligence-why-it-is-critical-for-life-sciences-companies","status":"publish","type":"post","link":"https:\/\/pharmanomos.ch\/en\/regulatory-due-diligence-why-it-is-critical-for-life-sciences-companies\/","title":{"rendered":"Regulatory Due Diligence: why it is critical for life sciences companies"},"content":{"rendered":"\n<p class=\"has-medium-font-size\">In the life sciences sector, acquisitions, mergers, investments and international expansion processes require much more in-depth evaluations than in other industries.<br\/>In the pharmaceutical, biotech, medical devices and healthcare world, in fact, the value of a company does not depend solely on economic or commercial data, but also on the strength of its regulatory system and the level of regulatory compliance achieved.<\/p>\n\n<p class=\"has-medium-font-size\">It is precisely in this context that regulatory due diligence takes on a strategic role.<\/p>\n\n<p class=\"has-medium-font-size\">For investors, CEOs, and entrepreneurs, properly analyzing regulatory aspects means reducing risks, avoiding unexpected costs, and understanding the true value of the company being acquired or partnered.<\/p>\n\n<div style=\"height:35px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n<h2 class=\"wp-block-heading\">What is regulatory due diligence<\/h2>\n\n<p class=\"has-medium-font-size\">Regulatory due diligence is an in-depth verification activity aimed at assessing the regulatory compliance of a company operating in the life sciences sector.<\/p>\n\n<p class=\"has-medium-font-size\">The goal is not only to identify any nonconformities, but to understand:<\/p>\n\n<ul class=\"wp-block-list has-medium-font-size\">\n<li>the maturity level of the quality system<\/li>\n\n\n\n<li>The sustainability of existing permits<\/li>\n\n\n\n<li>the reliability of technical documentation<\/li>\n\n\n\n<li>The regulatory risk associated with corporate activity<\/li>\n\n\n\n<li>The company&#8217;s ability to maintain compliance over time<\/li>\n<\/ul>\n\n<p class=\"has-medium-font-size\">In the pharmaceutical and medical sector, even seemingly minor critical issues can generate major consequences for business value, operations, and the ability to market products in certain markets.<\/p>\n\n<div style=\"height:35px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n<h2 class=\"wp-block-heading has-large-font-size\">Why it is crucial in M&amp;A transactions<\/h2>\n\n<p class=\"has-medium-font-size\">During merger &amp; acquisition (M&amp;A) transactions, regulatory due diligence allows us to verify whether the target company is truly operating in compliance with applicable regulations.<\/p>\n\n<p class=\"has-medium-font-size\">A business may appear economically sound but hide regulatory issues that can undermine the entire operation.<\/p>\n\n<p class=\"has-medium-font-size\">The main aspects analyzed include:<\/p>\n\n<ul class=\"wp-block-list has-medium-font-size\">\n<li>authorizations and operating licenses<\/li>\n\n\n\n<li>Compliance with applicable regulations (GMP\/ GDP, MDR\/IVDR) and adopted quality standards (e.g., ISO 13485)<\/li>\n\n\n\n<li>status of inspections received<\/li>\n\n\n\n<li>detour management and CAPA<\/li>\n\n\n\n<li>technical documentation and regulatory files<\/li>\n\n\n\n<li>management of qualified suppliers<\/li>\n\n\n\n<li>Pharmacovigilance activities or post-market surveillance<\/li>\n\n\n\n<li>Third-party contracts and regulatory responsibilities<\/li>\n\n\n\n<li>management of regulatory changes<\/li>\n<\/ul>\n\n<p class=\"has-medium-font-size\">Incomplete evaluation of these elements may result in:<\/p>\n\n<ul class=\"wp-block-list has-medium-font-size\">\n<li>delays in the operation<\/li>\n\n\n\n<li>high remediation costs<\/li>\n\n\n\n<li>trading blocks<\/li>\n\n\n\n<li>regulatory sanctions<\/li>\n\n\n\n<li>loss of authorizations<\/li>\n\n\n\n<li>reduction in estimated enterprise value<\/li>\n<\/ul>\n\n<div class=\"wp-block-uagb-info-box uagb-block-3966eb25 uagb-infobox__content-wrap  uagb-infobox-icon-above-title uagb-infobox-image-valign-top wp-block-uagb-info-box--has-margin link-verde\"><div class=\"uagb-infobox-margin-wrapper\"><div class=\"uagb-ifb-content\"><div class=\"uagb-ifb-title-wrap\"><h3 class=\"uagb-ifb-title\">Is your company ready to undertake regulatory due diligence?<\/h3><\/div><div class=\"uagb-ifb-separator\"><\/div><p class=\"uagb-ifb-desc\">Many life sciences companies discover critical regulatory issues only during investment transactions, acquisitions, or audits by external partners.<br\/><br\/>The most frequent issues include:<br\/>Incomplete assessment of regulatory compliance<br\/>Outdated technical documentation<br\/>Gaps in quality system and GMP\/GDP management<br\/>Regulatory roles and responsibilities not clearly defined<br\/><br\/>A preventive audit allows for quick identification of possible risks and reinforces the value of the company prior to strategic transactions.<br\/><br\/><strong>Request an audit<\/strong><\/p><div class=\"uagb-ifb-button-wrapper wp-block-button\"><a href=\"https:\/\/pharmanomos.ch\/en\/contact\/\" class=\"uagb-infobox-cta-link wp-block-button__link\" target=\"_blank\" rel=\"noopener noreferrer\" onclick=\"return true;\"><span class=\"uagb-inline-editing\">Analyze your level of regulatory compliance<\/span><\/a><\/div><\/div><\/div><\/div>\n\n<div style=\"height:35px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n<h2 class=\"wp-block-heading has-large-font-size\">The Swiss and international context<\/h2>\n\n<p class=\"has-medium-font-size\">In the Swiss context, life sciences companies operate within a particularly strict and dynamic regulatory framework.<\/p>\n\n<p class=\"has-medium-font-size\">Activities may be subject to oversight by agencies such as Swissmedic, as well as European and international regulations, especially in cases of export or presence in multiple markets.<\/p>\n\n<p class=\"has-medium-font-size\">This makes regulatory due diligence even more important in the operations of:<\/p>\n\n<ul class=\"wp-block-list has-medium-font-size\">\n<li>acquisition of pharmaceutical companies<\/li>\n\n\n\n<li>international expansion<\/li>\n\n\n\n<li>opening of new operational offices<\/li>\n\n\n\n<li>strategic partnerships<\/li>\n\n\n\n<li>investments by funds or venture capital<\/li>\n\n\n\n<li>integration of complex supply chains<\/li>\n<\/ul>\n\n<p class=\"has-medium-font-size\">For investors, understanding the level of regulatory exposure is as critical as assessing revenue, EBITDA, or business prospects.<\/p>\n\n<div style=\"height:35px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n<h2 class=\"wp-block-heading has-large-font-size\">The most critical areas to check<\/h2>\n\n<p class=\"has-medium-font-size\">Effective regulatory due diligence must be structured and multidisciplinary.<\/p>\n\n<p class=\"has-medium-font-size\">Some of the most sensitive areas include:<\/p>\n\n<h3 class=\"wp-block-heading has-medium-font-size\">Quality Management System<\/h3>\n\n<p class=\"has-medium-font-size\">The presence of up-to-date procedures, documented controls and traceable processes is a key indicator of business maturity.<\/p>\n\n<p class=\"has-medium-font-size\">A fragile quality system increases the risk of future noncompliance.<\/p>\n\n<h3 class=\"wp-block-heading has-medium-font-size\">GMP\/GDP Compliance<\/h3>\n\n<p class=\"has-medium-font-size\">In the pharmaceutical sector, any critical issues related to Good Manufacturing Practice or Good Distribution Practice can have immediate impacts on business continuity.<\/p>\n\n<h3 class=\"wp-block-heading has-medium-font-size\">Regulatory documentation<\/h3>\n\n<p class=\"has-medium-font-size\">Incomplete dossiers, outdated documents or technical inconsistencies may jeopardize authorizations and registrations.<\/p>\n\n<h3 class=\"wp-block-heading has-medium-font-size\">Previous audits and inspections<\/h3>\n\n<p class=\"has-medium-font-size\">Analysis of internal audits, regulatory inspections, and any observations received allows the company&#8217;s true compliance status to be assessed.<\/p>\n\n<h3 class=\"wp-block-heading has-medium-font-size\">Supplier management<\/h3>\n\n<p class=\"has-medium-font-size\">Life sciences companies depend heavily on external partners and qualified suppliers.<br\/>Insufficient supply chain management can pose a significant risk.<\/p>\n\n<div style=\"height:35px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n<h2 class=\"wp-block-heading has-large-font-size\">Also a strategic element for startups and scale-ups<\/h2>\n\n<p class=\"has-medium-font-size\">Regulatory due diligence is not only about large multinational corporations or complex operations.<\/p>\n\n<p class=\"has-medium-font-size\">Even biotech startups, innovative companies, and growth-stage entities can benefit enormously from a prior review of their regulatory structure.<\/p>\n\n<p class=\"has-medium-font-size\">Many investors today consider compliance an essential parameter in risk assessment.<\/p>\n\n<p class=\"has-medium-font-size\">A company with sound regulatory processes conveys greater reliability, reduces uncertainties and increases its attractiveness in the market.<\/p>\n\n<p class=\"has-medium-font-size\">Preparing in advance also allows you to:<\/p>\n\n<ul class=\"wp-block-list has-medium-font-size\">\n<li>accelerate investment processes<\/li>\n\n\n\n<li>improve corporate credibility<\/li>\n\n\n\n<li>Reduce future corrective costs<\/li>\n\n\n\n<li>Avoid delays in international growth<\/li>\n<\/ul>\n\n<div style=\"height:35px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n<h2 class=\"wp-block-heading has-large-font-size\">Due diligence as a value tool<\/h2>\n\n<p class=\"has-medium-font-size\">Due diligence is often perceived exclusively as an audit activity.<\/p>\n\n<p class=\"has-medium-font-size\">In fact, if managed correctly, it represents a strategic tool for value creation.<\/p>\n\n<p class=\"has-medium-font-size\">In fact, a thorough regulatory assessment makes it possible to:<\/p>\n\n<ul class=\"wp-block-list has-medium-font-size\">\n<li>identify areas for improvement<\/li>\n\n\n\n<li>strengthen the quality system<\/li>\n\n\n\n<li>increase corporate transparency<\/li>\n\n\n\n<li>improve internal governance<\/li>\n\n\n\n<li>Facilitate future extraordinary transactions<\/li>\n<\/ul>\n\n<p class=\"has-medium-font-size\">In the life sciences sector, where compliance and business continuity are closely linked, the regulatory component cannot be treated as a secondary issue.<\/p>\n\n<div style=\"height:35px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n<h2 class=\"wp-block-heading has-large-font-size\">Conclusions<\/h2>\n\n<p class=\"has-medium-font-size\">In the pharmaceutical and life sciences world, regulatory compliance is as much a strategic asset as economic performance.<\/p>\n\n<p class=\"has-medium-font-size\">During M&amp;A transactions, investments, or expansion processes, thorough regulatory due diligence enables the identification of hidden risks, protection of investment value, and greater long-term sustainability.<\/p>\n\n<p class=\"has-medium-font-size\">For CEOs, investors and entrepreneurs, integrating regulatory assessment into decision-making processes means taking a more informed, structured and growth-oriented approach.<\/p>\n\n<div style=\"height:35px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n<div class=\"wp-block-uagb-info-box uagb-block-763c1f83 uagb-infobox__content-wrap  uagb-infobox-icon-above-title uagb-infobox-image-valign-top wp-block-uagb-info-box--has-margin link-verde\"><div class=\"uagb-infobox-margin-wrapper\"><div class=\"uagb-ifb-content\"><div class=\"uagb-ifb-title-wrap\"><h3 class=\"uagb-ifb-title\">Regulatory due diligence: better safe than sorry<\/h3><\/div><div class=\"uagb-ifb-separator\"><\/div><p class=\"uagb-ifb-desc\">In the pharmaceutical and life sciences sector, even small noncompliances can turn into economic, operational and reputational risks during M&amp;A transactions or international expansion.<br\/><br\/>The most critical areas often include:<br\/>Improperly managed authorizations and licenses<br\/>Inadequately structured quality system<br\/>Incomplete or inconsistent regulatory documentation<br\/>Insufficient CAPA audit and management processes<br\/><br\/>Structured regulatory due diligence can reduce risk, increase transparency, and support stronger strategic decisions.<br\/><br\/><strong>Request an audit<\/strong><\/p><div class=\"uagb-ifb-button-wrapper wp-block-button\"><a href=\"https:\/\/pharmanomos.ch\/en\/contact\/\" class=\"uagb-infobox-cta-link wp-block-button__link\" target=\"_blank\" rel=\"noopener noreferrer\" onclick=\"return true;\"><span class=\"uagb-inline-editing\">Assess your life sciences company&#8217;s compliance<\/span><\/a><\/div><\/div><\/div><\/div>\n","protected":false},"excerpt":{"rendered":"<p>In the life sciences sector, acquisitions, mergers, investments and international expansion processes require much more in-depth evaluations than in other industries.In the pharmaceutical, biotech, medical devices and healthcare world, in fact, the value of a company does not depend solely on economic or commercial data, but also on the strength of its regulatory system and [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":5844,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_uag_custom_page_level_css":"","site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"categories":[1],"tags":[],"class_list":["post-5843","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-senza-categoria"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.6 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Pharmaceutical due diligence: why it is crucial in M&amp;A deals<\/title>\n<meta name=\"description\" content=\"Learn why regulatory due diligence is critical in M&amp;A deals and expansion processes for life sciences and pharmaceutical companies in Switzerland.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharmanomos.ch\/en\/regulatory-due-diligence-why-it-is-critical-for-life-sciences-companies\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Pharmaceutical due diligence: why it is crucial in M&amp;A deals\" \/>\n<meta property=\"og:description\" content=\"Learn why regulatory due diligence is critical in M&amp;A deals and expansion processes for life sciences and pharmaceutical companies in Switzerland.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharmanomos.ch\/en\/regulatory-due-diligence-why-it-is-critical-for-life-sciences-companies\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharmanomos Sagl \u2013 Consulenza e Sistemi Qualit\u00e0 per Farmacie in Svizzera\" \/>\n<meta property=\"article:published_time\" content=\"2026-05-20T06:01:01+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-05-20T06:08:56+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/pharmanomos.ch\/wp-content\/uploads\/2026\/05\/Due-diligence-regolatoria-nel-settore-life-sciences.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1536\" \/>\n\t<meta property=\"og:image:height\" content=\"1024\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/webp\" \/>\n<meta name=\"author\" content=\"giuseppe.cantoni.marketer@gmail.com\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"giuseppe.cantoni.marketer@gmail.com\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"5 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharmanomos.ch\\\/en\\\/regulatory-due-diligence-why-it-is-critical-for-life-sciences-companies\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharmanomos.ch\\\/en\\\/regulatory-due-diligence-why-it-is-critical-for-life-sciences-companies\\\/\"},\"author\":{\"name\":\"giuseppe.cantoni.marketer@gmail.com\",\"@id\":\"https:\\\/\\\/pharmanomos.ch\\\/en\\\/#\\\/schema\\\/person\\\/63997ce71a35d3b996aaa2af93f1fa71\"},\"headline\":\"Regulatory Due Diligence: why it is critical for life sciences companies\",\"datePublished\":\"2026-05-20T06:01:01+00:00\",\"dateModified\":\"2026-05-20T06:08:56+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharmanomos.ch\\\/en\\\/regulatory-due-diligence-why-it-is-critical-for-life-sciences-companies\\\/\"},\"wordCount\":990,\"publisher\":{\"@id\":\"https:\\\/\\\/pharmanomos.ch\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharmanomos.ch\\\/en\\\/regulatory-due-diligence-why-it-is-critical-for-life-sciences-companies\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/pharmanomos.ch\\\/wp-content\\\/uploads\\\/2026\\\/05\\\/Due-diligence-regolatoria-nel-settore-life-sciences.webp\",\"articleSection\":[\"Senza categoria\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharmanomos.ch\\\/en\\\/regulatory-due-diligence-why-it-is-critical-for-life-sciences-companies\\\/\",\"url\":\"https:\\\/\\\/pharmanomos.ch\\\/en\\\/regulatory-due-diligence-why-it-is-critical-for-life-sciences-companies\\\/\",\"name\":\"Pharmaceutical due diligence: why it is crucial in M&A deals\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharmanomos.ch\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharmanomos.ch\\\/en\\\/regulatory-due-diligence-why-it-is-critical-for-life-sciences-companies\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharmanomos.ch\\\/en\\\/regulatory-due-diligence-why-it-is-critical-for-life-sciences-companies\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/pharmanomos.ch\\\/wp-content\\\/uploads\\\/2026\\\/05\\\/Due-diligence-regolatoria-nel-settore-life-sciences.webp\",\"datePublished\":\"2026-05-20T06:01:01+00:00\",\"dateModified\":\"2026-05-20T06:08:56+00:00\",\"description\":\"Learn why regulatory due diligence is critical in M&A deals and expansion processes for life sciences and pharmaceutical companies in Switzerland.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharmanomos.ch\\\/en\\\/regulatory-due-diligence-why-it-is-critical-for-life-sciences-companies\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharmanomos.ch\\\/en\\\/regulatory-due-diligence-why-it-is-critical-for-life-sciences-companies\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharmanomos.ch\\\/en\\\/regulatory-due-diligence-why-it-is-critical-for-life-sciences-companies\\\/#primaryimage\",\"url\":\"https:\\\/\\\/pharmanomos.ch\\\/wp-content\\\/uploads\\\/2026\\\/05\\\/Due-diligence-regolatoria-nel-settore-life-sciences.webp\",\"contentUrl\":\"https:\\\/\\\/pharmanomos.ch\\\/wp-content\\\/uploads\\\/2026\\\/05\\\/Due-diligence-regolatoria-nel-settore-life-sciences.webp\",\"width\":1536,\"height\":1024,\"caption\":\"Managers and investors during a regulatory due diligence process at a Swiss pharmaceutical company\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharmanomos.ch\\\/en\\\/regulatory-due-diligence-why-it-is-critical-for-life-sciences-companies\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/pharmanomos.ch\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Regulatory Due Diligence: why it is critical for life sciences companies\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharmanomos.ch\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharmanomos.ch\\\/en\\\/\",\"name\":\"Pharmanomos Sagl \u2013 Consulenza e Sistemi Qualit\u00e0 per Farmacie in Svizzera\",\"description\":\"Soluzioni su misura per la gestione della qualit\u00e0 nelle farmacie. Consulenza specializzata, documentazione digitale e area clienti riservata.\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharmanomos.ch\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharmanomos.ch\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharmanomos.ch\\\/en\\\/#organization\",\"name\":\"Pharmanomos Sagl \u2013 Consulenza e Sistemi Qualit\u00e0 per Farmacie in Svizzera\",\"url\":\"https:\\\/\\\/pharmanomos.ch\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharmanomos.ch\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/pharmanomos.ch\\\/wp-content\\\/uploads\\\/2025\\\/05\\\/cropped-Logo-Pharmanomos-1-1.png\",\"contentUrl\":\"https:\\\/\\\/pharmanomos.ch\\\/wp-content\\\/uploads\\\/2025\\\/05\\\/cropped-Logo-Pharmanomos-1-1.png\",\"width\":766,\"height\":300,\"caption\":\"Pharmanomos Sagl \u2013 Consulenza e Sistemi Qualit\u00e0 per Farmacie in Svizzera\"},\"image\":{\"@id\":\"https:\\\/\\\/pharmanomos.ch\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.linkedin.com\\\/company\\\/pharmanomos-sagl\\\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharmanomos.ch\\\/en\\\/#\\\/schema\\\/person\\\/63997ce71a35d3b996aaa2af93f1fa71\",\"name\":\"giuseppe.cantoni.marketer@gmail.com\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/86b45b79a7c5cbaa8ca0bac39a5abc2ab5a88326e9adb469614a07550afd15c8?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/86b45b79a7c5cbaa8ca0bac39a5abc2ab5a88326e9adb469614a07550afd15c8?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/86b45b79a7c5cbaa8ca0bac39a5abc2ab5a88326e9adb469614a07550afd15c8?s=96&d=mm&r=g\",\"caption\":\"giuseppe.cantoni.marketer@gmail.com\"},\"sameAs\":[\"https:\\\/\\\/pharmanomos.ch\"],\"url\":\"https:\\\/\\\/pharmanomos.ch\\\/en\\\/author\\\/giuseppe-cantoni-marketergmail-com\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Pharmaceutical due diligence: why it is crucial in M&A deals","description":"Learn why regulatory due diligence is critical in M&A deals and expansion processes for life sciences and pharmaceutical companies in Switzerland.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharmanomos.ch\/en\/regulatory-due-diligence-why-it-is-critical-for-life-sciences-companies\/","og_locale":"en_US","og_type":"article","og_title":"Pharmaceutical due diligence: why it is crucial in M&A deals","og_description":"Learn why regulatory due diligence is critical in M&A deals and expansion processes for life sciences and pharmaceutical companies in Switzerland.","og_url":"https:\/\/pharmanomos.ch\/en\/regulatory-due-diligence-why-it-is-critical-for-life-sciences-companies\/","og_site_name":"Pharmanomos Sagl \u2013 Consulenza e Sistemi Qualit\u00e0 per Farmacie in Svizzera","article_published_time":"2026-05-20T06:01:01+00:00","article_modified_time":"2026-05-20T06:08:56+00:00","og_image":[{"width":1536,"height":1024,"url":"https:\/\/pharmanomos.ch\/wp-content\/uploads\/2026\/05\/Due-diligence-regolatoria-nel-settore-life-sciences.webp","type":"image\/webp"}],"author":"giuseppe.cantoni.marketer@gmail.com","twitter_card":"summary_large_image","twitter_misc":{"Written by":"giuseppe.cantoni.marketer@gmail.com","Est. reading time":"5 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharmanomos.ch\/en\/regulatory-due-diligence-why-it-is-critical-for-life-sciences-companies\/#article","isPartOf":{"@id":"https:\/\/pharmanomos.ch\/en\/regulatory-due-diligence-why-it-is-critical-for-life-sciences-companies\/"},"author":{"name":"giuseppe.cantoni.marketer@gmail.com","@id":"https:\/\/pharmanomos.ch\/en\/#\/schema\/person\/63997ce71a35d3b996aaa2af93f1fa71"},"headline":"Regulatory Due Diligence: why it is critical for life sciences companies","datePublished":"2026-05-20T06:01:01+00:00","dateModified":"2026-05-20T06:08:56+00:00","mainEntityOfPage":{"@id":"https:\/\/pharmanomos.ch\/en\/regulatory-due-diligence-why-it-is-critical-for-life-sciences-companies\/"},"wordCount":990,"publisher":{"@id":"https:\/\/pharmanomos.ch\/en\/#organization"},"image":{"@id":"https:\/\/pharmanomos.ch\/en\/regulatory-due-diligence-why-it-is-critical-for-life-sciences-companies\/#primaryimage"},"thumbnailUrl":"https:\/\/pharmanomos.ch\/wp-content\/uploads\/2026\/05\/Due-diligence-regolatoria-nel-settore-life-sciences.webp","articleSection":["Senza categoria"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharmanomos.ch\/en\/regulatory-due-diligence-why-it-is-critical-for-life-sciences-companies\/","url":"https:\/\/pharmanomos.ch\/en\/regulatory-due-diligence-why-it-is-critical-for-life-sciences-companies\/","name":"Pharmaceutical due diligence: why it is crucial in M&A deals","isPartOf":{"@id":"https:\/\/pharmanomos.ch\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharmanomos.ch\/en\/regulatory-due-diligence-why-it-is-critical-for-life-sciences-companies\/#primaryimage"},"image":{"@id":"https:\/\/pharmanomos.ch\/en\/regulatory-due-diligence-why-it-is-critical-for-life-sciences-companies\/#primaryimage"},"thumbnailUrl":"https:\/\/pharmanomos.ch\/wp-content\/uploads\/2026\/05\/Due-diligence-regolatoria-nel-settore-life-sciences.webp","datePublished":"2026-05-20T06:01:01+00:00","dateModified":"2026-05-20T06:08:56+00:00","description":"Learn why regulatory due diligence is critical in M&A deals and expansion processes for life sciences and pharmaceutical companies in Switzerland.","breadcrumb":{"@id":"https:\/\/pharmanomos.ch\/en\/regulatory-due-diligence-why-it-is-critical-for-life-sciences-companies\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharmanomos.ch\/en\/regulatory-due-diligence-why-it-is-critical-for-life-sciences-companies\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharmanomos.ch\/en\/regulatory-due-diligence-why-it-is-critical-for-life-sciences-companies\/#primaryimage","url":"https:\/\/pharmanomos.ch\/wp-content\/uploads\/2026\/05\/Due-diligence-regolatoria-nel-settore-life-sciences.webp","contentUrl":"https:\/\/pharmanomos.ch\/wp-content\/uploads\/2026\/05\/Due-diligence-regolatoria-nel-settore-life-sciences.webp","width":1536,"height":1024,"caption":"Managers and investors during a regulatory due diligence process at a Swiss pharmaceutical company"},{"@type":"BreadcrumbList","@id":"https:\/\/pharmanomos.ch\/en\/regulatory-due-diligence-why-it-is-critical-for-life-sciences-companies\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/pharmanomos.ch\/en\/"},{"@type":"ListItem","position":2,"name":"Regulatory Due Diligence: why it is critical for life sciences companies"}]},{"@type":"WebSite","@id":"https:\/\/pharmanomos.ch\/en\/#website","url":"https:\/\/pharmanomos.ch\/en\/","name":"Pharmanomos Sagl \u2013 Consulenza e Sistemi Qualit\u00e0 per Farmacie in Svizzera","description":"Soluzioni su misura per la gestione della qualit\u00e0 nelle farmacie. Consulenza specializzata, documentazione digitale e area clienti riservata.","publisher":{"@id":"https:\/\/pharmanomos.ch\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharmanomos.ch\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharmanomos.ch\/en\/#organization","name":"Pharmanomos Sagl \u2013 Consulenza e Sistemi Qualit\u00e0 per Farmacie in Svizzera","url":"https:\/\/pharmanomos.ch\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharmanomos.ch\/en\/#\/schema\/logo\/image\/","url":"https:\/\/pharmanomos.ch\/wp-content\/uploads\/2025\/05\/cropped-Logo-Pharmanomos-1-1.png","contentUrl":"https:\/\/pharmanomos.ch\/wp-content\/uploads\/2025\/05\/cropped-Logo-Pharmanomos-1-1.png","width":766,"height":300,"caption":"Pharmanomos Sagl \u2013 Consulenza e Sistemi Qualit\u00e0 per Farmacie in Svizzera"},"image":{"@id":"https:\/\/pharmanomos.ch\/en\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.linkedin.com\/company\/pharmanomos-sagl\/"]},{"@type":"Person","@id":"https:\/\/pharmanomos.ch\/en\/#\/schema\/person\/63997ce71a35d3b996aaa2af93f1fa71","name":"giuseppe.cantoni.marketer@gmail.com","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/86b45b79a7c5cbaa8ca0bac39a5abc2ab5a88326e9adb469614a07550afd15c8?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/86b45b79a7c5cbaa8ca0bac39a5abc2ab5a88326e9adb469614a07550afd15c8?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/86b45b79a7c5cbaa8ca0bac39a5abc2ab5a88326e9adb469614a07550afd15c8?s=96&d=mm&r=g","caption":"giuseppe.cantoni.marketer@gmail.com"},"sameAs":["https:\/\/pharmanomos.ch"],"url":"https:\/\/pharmanomos.ch\/en\/author\/giuseppe-cantoni-marketergmail-com\/"}]}},"uagb_featured_image_src":{"full":["https:\/\/pharmanomos.ch\/wp-content\/uploads\/2026\/05\/Due-diligence-regolatoria-nel-settore-life-sciences.webp",1536,1024,false],"thumbnail":["https:\/\/pharmanomos.ch\/wp-content\/uploads\/2026\/05\/Due-diligence-regolatoria-nel-settore-life-sciences-150x150.webp",150,150,true],"medium":["https:\/\/pharmanomos.ch\/wp-content\/uploads\/2026\/05\/Due-diligence-regolatoria-nel-settore-life-sciences-300x200.webp",300,200,true],"medium_large":["https:\/\/pharmanomos.ch\/wp-content\/uploads\/2026\/05\/Due-diligence-regolatoria-nel-settore-life-sciences-768x512.webp",768,512,true],"large":["https:\/\/pharmanomos.ch\/wp-content\/uploads\/2026\/05\/Due-diligence-regolatoria-nel-settore-life-sciences-1024x683.webp",1024,683,true],"1536x1536":["https:\/\/pharmanomos.ch\/wp-content\/uploads\/2026\/05\/Due-diligence-regolatoria-nel-settore-life-sciences.webp",1536,1024,false],"2048x2048":["https:\/\/pharmanomos.ch\/wp-content\/uploads\/2026\/05\/Due-diligence-regolatoria-nel-settore-life-sciences.webp",1536,1024,false]},"uagb_author_info":{"display_name":"giuseppe.cantoni.marketer@gmail.com","author_link":"https:\/\/pharmanomos.ch\/en\/author\/giuseppe-cantoni-marketergmail-com\/"},"uagb_comment_info":0,"uagb_excerpt":"In the life sciences sector, acquisitions, mergers, investments and international expansion processes require much more in-depth evaluations than in other industries.In the pharmaceutical, biotech, medical devices and healthcare world, in fact, the value of a company does not depend solely on economic or commercial data, but also on the strength of its regulatory system and&hellip;","_links":{"self":[{"href":"https:\/\/pharmanomos.ch\/en\/wp-json\/wp\/v2\/posts\/5843","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharmanomos.ch\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharmanomos.ch\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharmanomos.ch\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/pharmanomos.ch\/en\/wp-json\/wp\/v2\/comments?post=5843"}],"version-history":[{"count":2,"href":"https:\/\/pharmanomos.ch\/en\/wp-json\/wp\/v2\/posts\/5843\/revisions"}],"predecessor-version":[{"id":5848,"href":"https:\/\/pharmanomos.ch\/en\/wp-json\/wp\/v2\/posts\/5843\/revisions\/5848"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/pharmanomos.ch\/en\/wp-json\/wp\/v2\/media\/5844"}],"wp:attachment":[{"href":"https:\/\/pharmanomos.ch\/en\/wp-json\/wp\/v2\/media?parent=5843"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharmanomos.ch\/en\/wp-json\/wp\/v2\/categories?post=5843"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharmanomos.ch\/en\/wp-json\/wp\/v2\/tags?post=5843"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}